IPO of Talaris Therapeutics.

Talaris Therapeutics, Inc. has placed 8 825 000 shares of common stock in an IPO at a price of $17 per share, which corresponds to the midpoint of the previously announced range ($16-18). Besides, Talaris has granted the underwriters a 30-days option to purchase up to 1 323 750 shares at at the public offering price.

The trading debut will take place on the Nasdaq Global Select Market on May 7, 2021 under the ticker symbol “TALS”.